Related Experiment Video
Updated: Mar 15, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Diagnostic Approach to Advanced Fibrotic Interstitial Lung Disease: Bringing Together Clinical, Radiologic, and
Brandon T Larsen, Maxwell L Smith, Brett M Elicker
1From the Department of Laboratory Medicine & Pathology (Drs Larsen, Smith, and Leslie), Mayo Clinic, Scottsdale, Arizona; the Department of Radiology (Dr Elicker), University of California, San Francisco; Juan Max Boettner Hospital (Drs Fernandez and Arbo-Oze de Morvil), Asunción, Paraguay; and the Department of Medicine (Dr Pereira), Federal University of São Paulo, São Paulo, Brazil.
Idiopathic pulmonary fibrosis (IPF) is a common lung scarring disease. This review details other fibrotic lung diseases that mimic IPF, aiding accurate diagnosis for better patient outcomes.
Area of Science:
- Pulmonology
- Pathology
- Radiology
Background:
- Idiopathic pulmonary fibrosis (IPF) is the most common progressive diffuse lung scarring in older adults.
- IPF histopathology shows usual interstitial pneumonia (UIP) pattern with heterogeneous fibrosis.
- Advanced lung fibrosis can be caused by entities other than IPF, posing diagnostic challenges.
Purpose of the Study:
- To address diagnostic dilemmas in advanced fibrotic lung disease.
- To review and differentiate other fibrotic lung diseases from IPF.
- To detail clinical, radiologic, and histopathologic features of alternative diagnoses.
Main Methods:
- Literature review of published peer-reviewed studies.
- Inclusion of authors' personal clinical experience.
- Comparative analysis of fibrotic lung diseases.
Main Results:
- Several fibrotic lung diseases share features with IPF, including connective tissue disease-associated ILD, hypersensitivity pneumonitis, and sarcoidosis.
- Distinctive clinical, radiologic, and histopathologic clues can differentiate these conditions from IPF.
- Surgical lung biopsies may reveal subtle findings suggestive of non-IPF etiologies.
Conclusions:
- Accurate classification of fibrotic lung disease is crucial for patient prognosis and treatment.
- Lung biopsy findings can be the initial indicator of a non-IPF fibrotic condition.
- Distinguishing IPF from other fibrotic lung diseases is essential for developing targeted therapies.
More Related Videos
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
03:38Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...